Silva Pharmaceuticals Limited reported earnings results for the first quarter ended September 30, 2021. For the first quarter, the company reported sales was BDT 215.85 million compared to BDT 227.52 million a year ago. Net income was BDT 39.11 million compared to BDT 47.17 million a year ago. Basic earnings per share from continuing operations was BDT 0.29 compared to BDT 0.35 a year ago.